chr13-100268802-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000282.4(PCCA):c.914+19A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.987 in 1,558,632 control chromosomes in the GnomAD database, including 760,753 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.93   (  66742   hom.,  cov: 32) 
 Exomes 𝑓:  0.99   (  694011   hom.  ) 
Consequence
 PCCA
NM_000282.4 intron
NM_000282.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.760  
Publications
7 publications found 
Genes affected
 PCCA  (HGNC:8653):  (propionyl-CoA carboxylase subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric mitochondrial enzyme Propionyl-CoA carboxylase. PCCA encodes the biotin-binding region of this enzyme. Mutations in either PCCA or PCCB (encoding the beta subunit) lead to an enzyme deficiency resulting in propionic acidemia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010] 
PCCA Gene-Disease associations (from GenCC):
- propionic acidemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BP6
Variant 13-100268802-A-G is Benign according to our data. Variant chr13-100268802-A-G is described in ClinVar as Benign. ClinVar VariationId is 92765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.931  AC: 141552AN: 152124Hom.:  66706  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
141552
AN: 
152124
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.981  AC: 245829AN: 250532 AF XY:  0.986   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
245829
AN: 
250532
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.993  AC: 1396161AN: 1406388Hom.:  694011  Cov.: 23 AF XY:  0.994  AC XY: 699020AN XY: 703480 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1396161
AN: 
1406388
Hom.: 
Cov.: 
23
 AF XY: 
AC XY: 
699020
AN XY: 
703480
show subpopulations 
African (AFR) 
 AF: 
AC: 
24428
AN: 
32404
American (AMR) 
 AF: 
AC: 
43980
AN: 
44654
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
25759
AN: 
25790
East Asian (EAS) 
 AF: 
AC: 
39410
AN: 
39410
South Asian (SAS) 
 AF: 
AC: 
85084
AN: 
85148
European-Finnish (FIN) 
 AF: 
AC: 
53380
AN: 
53380
Middle Eastern (MID) 
 AF: 
AC: 
5596
AN: 
5668
European-Non Finnish (NFE) 
 AF: 
AC: 
1060924
AN: 
1061392
Other (OTH) 
 AF: 
AC: 
57600
AN: 
58542
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 397 
 793 
 1190 
 1586 
 1983 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20302 
 40604 
 60906 
 81208 
 101510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.930  AC: 141644AN: 152244Hom.:  66742  Cov.: 32 AF XY:  0.932  AC XY: 69376AN XY: 74462 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
141644
AN: 
152244
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
69376
AN XY: 
74462
show subpopulations 
African (AFR) 
 AF: 
AC: 
31479
AN: 
41480
American (AMR) 
 AF: 
AC: 
14872
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3469
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
5179
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
4821
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
10624
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
289
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
67977
AN: 
68036
Other (OTH) 
 AF: 
AC: 
2022
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 409 
 819 
 1228 
 1638 
 2047 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 902 
 1804 
 2706 
 3608 
 4510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3422
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:11 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jun 11, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Propionic acidemia    Benign:4 
Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:3 
Feb 29, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.